300453SZSE

Sanxin Medical Co., Ltd.

三鑫医疗

300453

Shenzhen Stock Exchange

Follow
18 announcements tracked· Last: May 20, 2026

Key Financials

Revenue¥408.9M
Net Profit¥68.4M
ROE4.47%
Debt Ratio33.76%
Monetary Funds¥183.8M
Receivables¥87.2M
Goodwill¥79.6M
Total Shares522.1M

Announcements

18 total

Announcement on the Implementation of the 2025 Annual Equity Distribution

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Election of Employee Representative Directors for the Sixth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Reminder announcement on the convening of the 2025 Annual General Meeting of Shareholders

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Listing Sponsorship Letter for Jiangxi Sanxin Medical Technology Co., Ltd.'s Issuance of Convertible Bonds to Unspecified Objects by Guojin Securities Co., Ltd.

Shareholder Share IncreaseShareholding Change DisclosureCapital Reduction

Fundraising Prospectus (Registration Draft) for Jiangxi Sanxin Medical Technology Co., Ltd.'s Issuance of Convertible Bonds to Unspecified Objects

Share Repurchase PlanShareholding Change DisclosureCapital Reduction

Reminder Announcement on Submitting the Fundraising Prospectus (Registration Draft) and Other Application Documents for Issuing Convertible Bonds to Unspecified Objects

Share Repurchase PlanShare Repurchase CompletionShareholding Change Disclosure

Sponsorship Letter for Jiangxi Sanxin Medical Technology Co., Ltd.'s Issuance of Convertible Bonds to Unspecified Objects by Guojin Securities Co., Ltd.

Shareholder Share IncreaseShareholding Change DisclosureCapital Reduction

Announcement on participation in the 2026 online collective reception day activity for investors of listed companies in Jiangxi jurisdiction

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Change of Office Address

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director 2025 Annual Work Report (Xia Xiaohua)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director 2025 Annual Work Report (Chen Guofeng)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director 2025 Annual Work Report (Liu Dongjing)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director 2025 Annual Work Report (Jiang Haihong)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on Holding an Online Performance Presentation for the 2025 Annual Results

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Internal Control Audit Report of Jiangxi Sanxin Medical Technology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Self-Assessment Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Compensation Management System (April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…